{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:45:05Z","timestamp":1787499905350,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005205","name":"Janssen Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials Communications"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.conctc.2020.100522","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T17:24:31Z","timestamp":1579022671000},"page":"100522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Cohort profile of a US military population for evaluating pre-disease and disease serological biomarkers in rheumatoid and reactive arthritis: Rationale, organization, design, and baseline characteristics"],"prefix":"10.1016","volume":"17","author":[{"given":"Chad K.","family":"Porter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Riddle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0559-4114","authenticated-orcid":false,"given":"Renee M.","family":"Laird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8609-118X","authenticated-orcid":false,"given":"Matthew","family":"Loza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Gariepy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0769-280X","authenticated-orcid":false,"given":"Ashley","family":"Alcala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro","family":"Gutierr\u00e9z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Baribaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navin L.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Nagpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.conctc.2020.100522_bib1","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/acr.20041","article-title":"Prevalence of specific types of arthritis and other rheumatic conditions in the ambulatory health care system in the United States, 2001-2005","volume":"62","author":"Sacks","year":"2010","journal-title":"Arthritis Care Res."},{"issue":"1","key":"10.1016\/j.conctc.2020.100522_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.23176","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II","volume":"58","author":"Lawrence","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.conctc.2020.100522_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/art.23177","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I","volume":"58","author":"Helmick","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"Suppl 1","key":"10.1016\/j.conctc.2020.100522_bib4","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1186\/1472-6874-4-S1-S18","article-title":"The impact of arthritis on Canadian women","volume":"4","author":"Badley","year":"2004","journal-title":"BMC Women's Health"},{"issue":"4","key":"10.1016\/j.conctc.2020.100522_bib5","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.semarthrit.2004.08.003","article-title":"Rheumatoid arthritis in American Indians and Alaska Natives: a review of the literature","volume":"34","author":"Ferucci","year":"2005","journal-title":"Semin. Arthritis Rheum."},{"issue":"Suppl 3","key":"10.1016\/j.conctc.2020.100522_bib6","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1186\/ar578","article-title":"Epidemiology and genetics of rheumatoid arthritis","volume":"4","author":"Silman","year":"2002","journal-title":"Arthritis Res."},{"issue":"2","key":"10.1016\/j.conctc.2020.100522_bib7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/rheumatology\/ker385","article-title":"Factors associated with absenteeism, presenteeism and activity impairment in patients in the first years of RA","volume":"51","author":"Bansback","year":"2012","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.conctc.2020.100522_bib8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1521-6942(02)00104-3","article-title":"Arthritis associated with enteric infection","volume":"17","author":"Hill Gaston","year":"2003","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"4","key":"10.1016\/j.conctc.2020.100522_bib9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/03009740500202540","article-title":"Reactive arthritis","volume":"34","author":"Leirisalo-Repo","year":"2005","journal-title":"Scand. J. Rheumatol."},{"issue":"3","key":"10.1016\/j.conctc.2020.100522_bib10","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/rheumatology\/41.3.312","article-title":"Campylobacter-triggered reactive arthritis: a population-based study","volume":"41","author":"Hannu","year":"2002","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.conctc.2020.100522_bib11","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/ard.61.5.448","article-title":"Comparison of rheumatological and gastrointestinal symptoms after infection with Campylobacter jejuni\/coli and enterotoxigenic Escherichia coli","volume":"61","author":"Locht","year":"2002","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.conctc.2020.100522_bib12","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/ard.2004.027524","article-title":"Reactive arthritis attributable to Shigella infection: a clinical and epidemiological nationwide study","volume":"64","author":"Hannu","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.conctc.2020.100522_bib13","first-page":"1","article-title":"A study of 344 cases observed in Finland","volume":"130","author":"Paronen","year":"1948","journal-title":"Acta Med. Scand."},{"issue":"5","key":"10.1016\/j.conctc.2020.100522_bib14","first-page":"845","article-title":"Reactive arthritis after Salmonella among medical doctors--study of an outbreak","volume":"20","author":"Locht","year":"1993","journal-title":"J. Rheumatol."},{"issue":"suppl 114","key":"10.1016\/j.conctc.2020.100522_bib15","article-title":"Reactive arthritis (ReA) after an outbreak of Salmonella enteriditis","volume":"29","author":"Locht","year":"2000","journal-title":"Scand. J. Rheumatol."},{"issue":"26","key":"10.1016\/j.conctc.2020.100522_bib16","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJM198312293092604","article-title":"Reiter's syndrome and reactive arthritis in perspective","volume":"309","author":"Keat","year":"1983","journal-title":"N. Engl. J. Med."},{"issue":"Suppl 3","key":"10.1016\/j.conctc.2020.100522_bib17","doi-asserted-by":"crossref","first-page":"S311","DOI":"10.1086\/381601","article-title":"Persistent diarrhea, arthritis, and other complications of enteric infections: a pilot survey based on California FoodNet surveillance, 1998-1999","volume":"38","author":"Rees","year":"2004","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"10.1016\/j.conctc.2020.100522_bib18","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1086\/322644","article-title":"Reactive arthritis and Reiter's syndrome following an outbreak of gastroenteritis caused by Salmonella enteritidis","volume":"33","author":"Dworkin","year":"2001","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.conctc.2020.100522_bib19","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/art.1780311106","article-title":"Postdysenteric reactive arthritis. A clinical and immunogenetic study following an outbreak of salmonellosis","volume":"31","author":"Inman","year":"1988","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.conctc.2020.100522_bib20","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1136\/ard.61.3.264","article-title":"Reactive arthritis following an outbreak of Salmonella typhimurium phage type 193 infection","volume":"61","author":"Hannu","year":"2002","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.conctc.2020.100522_bib21","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jama.1966.03110200049016","article-title":"An \"experimental\" epidemic of Reiter's syndrome","volume":"198","author":"Noer","year":"1966","journal-title":"J. Am. Med. Assoc."},{"issue":"2","key":"10.1016\/j.conctc.2020.100522_bib22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/infdis\/149.2.245","article-title":"An outbreak of Yersinia pseudotuberculosis infection","volume":"149","author":"Tertti","year":"1984","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.conctc.2020.100522_bib23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.semarthrit.2006.12.006","article-title":"Campylobacter reactive arthritis: a systematic review","volume":"37","author":"Pope","year":"2007","journal-title":"Semin. Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.conctc.2020.100522_bib24","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1590\/S0482-50042012000400006","article-title":"The association between serum levels of potential biomarkers with the presence of factors related to the clinical activity and poor prognosis in spondyloarthritis","volume":"52","author":"Londono","year":"2012","journal-title":"Rev. Bras. Reumatol."},{"issue":"12","key":"10.1016\/j.conctc.2020.100522_bib25","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.2105\/AJPH.92.12.1900","article-title":"The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance","volume":"92","author":"Rubertone","year":"2002","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.conctc.2020.100522_bib26","doi-asserted-by":"crossref","first-page":"100345","DOI":"10.1016\/j.conctc.2019.100345","article-title":"Cohort profile of the PRoteomic evaluation and discovery in an IBD cohort of tri-service subjects (PREDICTS) study: rationale, organization, design, and baseline characteristics","volume":"14","author":"Porter","year":"2019","journal-title":"Contemp Clin Trials Commun"},{"issue":"4","key":"10.1016\/j.conctc.2020.100522_bib27","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/1756-185X.12129","article-title":"Anti-citrullinated protein antibodies and their clinical utility in rheumatoid arthritis","volume":"16","author":"Farid","year":"2013","journal-title":"Int J Rheum Dis"},{"issue":"S2","key":"10.1016\/j.conctc.2020.100522_bib28","doi-asserted-by":"crossref","first-page":"4","DOI":"10.7205\/MILMED-D-17-00064","article-title":"Travelers' diarrhea: an update on the incidence, etiology, and risk in military deployments and similar travel populations","volume":"182","author":"Porter","year":"2017","journal-title":"Mil. Med."},{"key":"10.1016\/j.conctc.2020.100522_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40794-018-0077-1","article-title":"Travelers' diarrhea: update on the incidence, etiology and risk in military and similar populations - 1990-2005 versus 2005-2015, does a decade make a difference?","volume":"5","author":"Olson","year":"2019","journal-title":"Trop Dis Travel Med Vaccines"},{"issue":"7","key":"10.1016\/j.conctc.2020.100522_bib30","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.clinthera.2019.04.028","article-title":"The natural history of rheumatoid arthritis","volume":"41","author":"Deane","year":"2019","journal-title":"Clin. Ther."},{"issue":"2","key":"10.1016\/j.conctc.2020.100522_bib31","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1124\/pr.114.009639","article-title":"Cytokines as therapeutic targets in rheumatoid arthritis and other inflammatory diseases","volume":"67","author":"Siebert","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.conctc.2020.100522_bib32","doi-asserted-by":"crossref","DOI":"10.1177\/2235042X19853484","article-title":"Morbidity and mortality in patients with rheumatoid arthritis compared with an age- and sex-matched control population: a nationwide register study","volume":"9","author":"Loppenthin","year":"2019","journal-title":"J. Comorbidity"},{"issue":"10","key":"10.1016\/j.conctc.2020.100522_bib33","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantapaa-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.conctc.2020.100522_bib34","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.conctc.2020.100522_bib35","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/ard.2007.076679","article-title":"Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis","volume":"67","author":"Majka","year":"2008","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.conctc.2020.100522_bib36","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/art.27570","article-title":"Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis","volume":"62","author":"Kolfenbach","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.conctc.2020.100522_bib37","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/ard.2008.105759","article-title":"Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study","volume":"69","author":"Bos","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.conctc.2020.100522_bib38","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/rheumatology\/kes371","article-title":"Monoclonal anti-citrullinated protein antibodies selected on citrullinated fibrinogen have distinct targets with different cross-reactivity patterns","volume":"52","author":"van de Stadt","year":"2013","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.conctc.2020.100522_bib39","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1136\/annrheumdis-2014-205227","article-title":"Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study","volume":"74","author":"Rakieh","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.conctc.2020.100522_bib40","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/annrheumdis-2013-204154","article-title":"Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis","volume":"73","author":"Shi","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.conctc.2020.100522_bib41","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3899\/jrheum.140767","article-title":"Anti-carbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis","volume":"42","author":"Gan","year":"2015","journal-title":"J. Rheumatol."},{"issue":"4","key":"10.1016\/j.conctc.2020.100522_bib42","first-page":"512","article-title":"Rheumatoid factor detection in the unaffected first degree relatives in families with multicase rheumatoid arthritis","volume":"18","author":"Silman","year":"1991","journal-title":"J. Rheumatol."},{"issue":"5","key":"10.1016\/j.conctc.2020.100522_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035296","article-title":"Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis","volume":"7","author":"Sokolove","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.conctc.2020.100522_bib44","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2174\/1574886313666180508122332","article-title":"Musculoskeletal and rheumatic diseases induced by immune checkpoint inhibitors: a review of the literature","volume":"13","author":"Benfaremo","year":"2018","journal-title":"Curr. Drug Saf."},{"issue":"2","key":"10.1016\/j.conctc.2020.100522_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192704","article-title":"Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progression","volume":"13","author":"Guo","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.conctc.2020.100522_bib46","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1741-7015-7-12","article-title":"Sex differences in rheumatoid arthritis: more than meets the eye","volume":"7","author":"van Vollenhoven","year":"2009","journal-title":"BMC Med."},{"issue":"2","key":"10.1016\/j.conctc.2020.100522_bib47","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1128\/CMR.17.2.348-369.2004","article-title":"HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations","volume":"17","author":"Colmegna","year":"2004","journal-title":"Clin. Microbiol. Rev."}],"updated-by":[{"DOI":"10.1016\/j.conctc.2020.100691","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000}}],"container-title":["Contemporary Clinical Trials Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865420300065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865420300065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:05:14Z","timestamp":1762520714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451865420300065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":47,"alternative-id":["S2451865420300065"],"URL":"https:\/\/doi.org\/10.1016\/j.conctc.2020.100522","relation":{},"ISSN":["2451-8654"],"issn-type":[{"value":"2451-8654","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cohort profile of a US military population for evaluating pre-disease and disease serological biomarkers in rheumatoid and reactive arthritis: Rationale, organization, design, and baseline characteristics","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conctc.2020.100522","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100522"}}